Is Abbott Laboratories overvalued?

Abbott Laboratories (ABT) looks overvalued — trading about 57% above its fair value.

Overvalued

Price

$93.82

Fair value

$40.34

Current P/E

25.2

Normal P/E

10.8

Market cap

$163.42B

Dividend yield

1.9%

Return on equity

12.5%

Sector

Healthcare

Fair value compares ABT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks